EMBC Stock: Embecta Corp. Stock Price, Analysis & Insights
Get live EMBC stock price $3.19, comprehensive Embecta Corp. stock analysis, charts, news, and expert forecast. Real-time EMBC stock data and investment insights.
Loading chart data...
Embecta Corp. (EMBC) Overview
Embecta Corp. (EMBC) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, EMBC trades at $3.19 with a market capitalization of 189.26M . Over the past 52 weeks, EMBC has traded between $2.77 and $15.55 , with the current price positioned at approximately 3% of this range . The stock ...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 189.26M
- Current price: $3.19
- 52-week range: $2.77 - $15.55
- P/E ratio: 1.69
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanc...
Company Information
- CEO
- Devdatt Kurdikar
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 2000
Contact Information
- Website
- https://www.embecta.com
- Address
- 300 Kimball Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 1.7)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Embecta Corp. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Embecta Corp.
- ⚠Investors should consider how Embecta Corp. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
189.26M
P/E Ratio (TTM)
1.69
Beta
0.81
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare EMBC with peer companies:
- Price
- $3.98
- Market cap
- 395.24M
- Price
- $23.48
- Market cap
- 1.21B
- Price
- $8.22
- Market cap
- 424.12M
- Price
- $4.51
- Market cap
- 506.73M
- Price
- $5.08
- Market cap
- 736.36M
- Price
- $4.46
- Market cap
- 420.77M
- Price
- $2.75
- Market cap
- 495.79M
- Price
- $9.67
- Market cap
- 858.74M
- Price
- $4.37
- Market cap
- 313.43M
- Price
- $8.23
- Market cap
- 1.39B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.